Stay updated on LGX818 and MEK162 With Third Agent in BRAF Melanoma Clinical Trial
Sign up to get notified when there's something new on the LGX818 and MEK162 With Third Agent in BRAF Melanoma Clinical Trial page.

Latest updates to the LGX818 and MEK162 With Third Agent in BRAF Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedA new revision entry (v3.3.2) was added to the history, replacing the previous v3.2.0; the rest of the History page layout remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the header notice about funding-related data currency and NIH operating status, which previously directed users to cc.nih.gov and opm.gov. The message was a system-level notification rather than core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check42 days agoChange DetectedThe new screenshot shows a redesigned header and a slightly adjusted layout of the version history table. No data or version entries appear to have changed.SummaryDifference0.1%

- Check71 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference10%

- Check78 days agoChange DetectedThe page updates its revision from v3.0.2 to v3.1.0, signaling a new version is available. No other substantive content changes are evident.SummaryDifference0.3%

- Check93 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.6%

Stay in the know with updates to LGX818 and MEK162 With Third Agent in BRAF Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LGX818 and MEK162 With Third Agent in BRAF Melanoma Clinical Trial page.